# Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea

> **NCT02229344** · — · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 368 (actual)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT02229344
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-01
- **Primary completion:** 2022-02-22
- **Final completion:** 2022-02-22
- **Target enrollment:** 368 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02229344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02229344, "Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02229344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*